Blueprint Medicines Corp
BPMC
Market Cap$5.55B
Close$
$95.39
2.5% upside
Current Fair Value
2.5% upsideUndervalued by 2.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.55 Billion |
|---|---|
| Enterprise Value | $5.08 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-8.37 |
| Beta | 0.0 |
| Outstanding Shares | 61,200,000 |
| Avg 30 Day Volume | 616,088 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -10.95 |
|---|---|
| PEG | 36.41 |
| Price to Sales | 23.28 |
| Price to Book Ratio | 46.55 |
| Enterprise Value to Revenue | 20.37 |
| Enterprise Value to EBIT | -10.54 |
| Enterprise Value to Net Income | -11 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 1.83 |
Revenue Sources
No data
ESG Score
No data
About Blueprint Medicines Corp
CEO: Jeffrey Albers